Follow the Syncona Limited stock price and the full management transaction log of the company, a listed equity based in United Kingdom. Shares are quoted on the UK market, under the supervision of RNS (LSE). Market capitalisation: €659.3m. The latest transaction was reported on 22 June 2026 (Purchase). Among the most active insiders: John Patrick Roche. All data is openly available.
Analysts rate Syncona Limited Strong Buy (bullish), based on 2 analysts. Average price target: £202.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Syncona Limited is an investment company focused on the life sciences sector, dedicated to developing innovative therapies. It is listed on the London Stock Exchange under the ticker XLON.